Novartis Pumps $15M Into Israeli Stem Cell Research Firm – Forward
|
Novartis Pumps $15M Into Israeli Stem Cell Research Firm
Forward The Swiss drug maker Novartis will invest an extra $15 million in Gamida Cell, an Israeli developer of stem cell therapies, Gamida said. Novartis last year invested $35 million in the company for a 15 percent stake, the Tachles Jewish weekly of … |
